TY - JOUR
T1 - Long-term therapy for pulmonary hypertension in children
AU - Dent, Catherine L.
AU - Pérez Fontán, J. Julio
PY - 1999
Y1 - 1999
N2 - This review recounts recent advances in the understanding and treatment of the processes that cause pulmonary hypertension in infancy and childhood. New discoveries have begun to unveil connections between the basic physiological mechanisms responsible for the regulation of pulmonary vascular tone and the abnormal responses of the pulmonary vasculature in a variety of disease conditions. These discoveries raise hope for new therapeutic interventions that may improve the high mortality and morbidity of both children and adults with pulmonary vascular disease. In the meantime, treatment efforts continue to be focused on the relief of pulmonary vasoconstriction with inhaled nitric oxide and intravenous prostacyclin in the short term and oral calcium channel blockers as the mainstay of long-term therapy. Lung transplantation often remains as the only viable option for continued survival when the pulmonary vascular disease is progressive. Curr Opin Pulm Med 1999, 5:390-594
AB - This review recounts recent advances in the understanding and treatment of the processes that cause pulmonary hypertension in infancy and childhood. New discoveries have begun to unveil connections between the basic physiological mechanisms responsible for the regulation of pulmonary vascular tone and the abnormal responses of the pulmonary vasculature in a variety of disease conditions. These discoveries raise hope for new therapeutic interventions that may improve the high mortality and morbidity of both children and adults with pulmonary vascular disease. In the meantime, treatment efforts continue to be focused on the relief of pulmonary vasoconstriction with inhaled nitric oxide and intravenous prostacyclin in the short term and oral calcium channel blockers as the mainstay of long-term therapy. Lung transplantation often remains as the only viable option for continued survival when the pulmonary vascular disease is progressive. Curr Opin Pulm Med 1999, 5:390-594
UR - http://www.scopus.com/inward/record.url?scp=0040032772&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0040032772&partnerID=8YFLogxK
U2 - 10.1097/00063198-199911000-00012
DO - 10.1097/00063198-199911000-00012
M3 - Article
AN - SCOPUS:0040032772
SN - 1070-5287
VL - 5
SP - 390
EP - 594
JO - Current Opinion in Pulmonary Medicine
JF - Current Opinion in Pulmonary Medicine
IS - 6
ER -